Jun 23
|
Life Science Investor Forum: Presentations Now Available for Online Viewing
|
Apr 27
|
ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes
|
Apr 25
|
ReShape Lifesciences® Reports Year Ended December 31, 2022 Financial Results and Provides Corporate Update
|